EU HE - ONCOVALUE Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time
Real-world data (RWD) on patient health status are collected from various sources, such as electronic health records and wearables. Harnessing the power of RWD is challenging but offers the possibility to unlock actionable healthcare insights.
The key objective of the EU-funded ONCOVALUE project is to collect and analyse RWD from European cancer hospitals and institutes as a means of assessing the effectiveness of novel cancer therapies. The consortium will use AI technologies to transform unstructured data from medical notes and images into real-world evidence made available to clinicians for treatment decision-making, and to regulatory bodies for developing guidelines. Collectively, ONCOVALUE will contribute to safer and more efficient therapies and technologies.
Link: https://cordis.europa.eu/project/id/101095245
Link: Home - Oncovalue
Programme | HORIZON EUROPE |
Call for proposal | |
Funding scheme | HORIZON-RIA |
Budget | €6,953,003.50 |
Start date | 1st december 2022 |
Duration | 48 months |
Ultimo aggiornamento: 06 luglio 2025, 15:51
Anche tu puoi fare molto per la lotta ai tumori!
Tu con Noi puoi sostenere la ricerca svolta ogni giorno nei nostri laboratori, puoi far sì che le cure siano sempre più efficaci, che il periodo di terapia sia vissuto più lievemente. I modi per farlo sono tanti.